Castellan Group Takes Position in McKesson Corporation $MCK

Key Points

• Castellan Group bought 8,130 shares of McKesson in Q4 (about $6.67M), making the stock its 10th-largest holding and ~0.8% of the firm's portfolio.
• Institutional ownership is high at 85.07% with several large funds (State Street, Franklin, AllianceBernstein, etc.) increasing positions, while insiders have sold 3,592 shares in the last 90 days and now own just 0.08% of the company.
• Analysts have a consensus "Moderate Buy" with an average target of $970.93; McKesson recently beat quarterly EPS and revenue estimates, reported revenue up 11.4% y/y, and set FY2026 guidance of 38.800–39.200 EPS.

Castellan Group bought a new stake in McKesson Corporation (NYSE:MCK - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 8,130 shares of the company's stock, valued at approximately $6,669,000. McKesson accounts for 0.8% of Castellan Group's investment portfolio, making the stock its 10th biggest holding.

Several other institutional investors have also modified their holdings of the stock. State Street Corp grew its position in shares of McKesson by 0.9% in the third quarter. State Street Corp now owns 5,750,519 shares of the company's stock valued at $4,447,110,000 after purchasing an additional 51,510 shares during the period. Franklin Resources Inc. grew its position in shares of McKesson by 3.5% in the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock valued at $2,071,428,000 after purchasing an additional 90,948 shares during the period. Alliancebernstein L.P. grew its position in shares of McKesson by 5.6% in the third quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock valued at $1,850,001,000 after purchasing an additional 126,684 shares during the period. Northern Trust Corp grew its position in shares of McKesson by 0.4% in the third quarter. Northern Trust Corp now owns 1,532,856 shares of the company's stock valued at $1,184,193,000 after purchasing an additional 6,613 shares during the period. Finally, Boston Partners grew its position in shares of McKesson by 6.7% in the third quarter. Boston Partners now owns 1,330,953 shares of the company's stock valued at $1,027,569,000 after purchasing an additional 83,357 shares during the period. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm's stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the firm's stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total transaction of $179,550.00. Following the sale, the executive vice president owned 2,989 shares of the company's stock, valued at approximately $2,824,605. The trade was a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,592 shares of company stock valued at $3,518,555 over the last ninety days. 0.08% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on MCK. Bank of America dropped their target price on shares of McKesson from $1,040.00 to $1,000.00 and set a "buy" rating on the stock in a research report on Monday, April 6th. Weiss Ratings lowered shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a research report on Thursday, February 5th. Leerink Partners reiterated an "outperform" rating and issued a $1,085.00 target price on shares of McKesson in a research report on Thursday, March 5th. TD Cowen lifted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the company a "buy" rating in a research report on Thursday, February 5th. Finally, Wells Fargo & Company increased their target price on shares of McKesson from $914.00 to $925.00 and gave the company an "equal weight" rating in a research report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, McKesson has a consensus rating of "Moderate Buy" and an average target price of $970.93.

McKesson Stock Up 0.0%

Shares of NYSE MCK opened at $866.02 on Monday. The firm has a 50-day simple moving average of $916.22 and a 200-day simple moving average of $851.87. The stock has a market capitalization of $106.08 billion, a price-to-earnings ratio of 24.91, a price-to-earnings-growth ratio of 1.25 and a beta of 0.42. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company's quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts expect that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Monday, March 2nd. McKesson's dividend payout ratio is 9.43%.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.